Revolutionizing Heart Failure Therapy: Harnessing IVT mRNA and Fusion Protein Technology to Prolong rhBNP Half-Life

Lihui Zou(Beijing Hospital)
Pharmaceutical Research
January 1, 2025
Cited by 2


Related Papers